viewBraveheart Investment Group

Braveheart updates on progress of investee firm Paraytec

Paraytec is conducting proof of concept for a COVID-19 test with the University of Sheffield

Braveheart Investment Group - Braveheart updates on progress of investee firm Paraytec

Braveheart Investment Group PLC (LON:BRH) has provided an update on the progress with proof of concept for a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.

The investment group said the proof of concept trials are focused on two separate elements of the test, the Optical Detection System, and Capture & Signal Generation Modules, both of which are required to be achieved for the trial to be successful.

READ: Braveheart Investment Group updates on progress of investee firm Phasefocus Holdings

Proof of concept has been achieved for the Optical Detection System and development work continues to optimise detection sensitivity, the AIM-listed firm said in a statement.

Minor logistical issues arising from increased regional COVID-19 restrictions has meant that final proof of concept trials continue for the Capture & Signal Generation Modules and the results are now anticipated on October 16, it added.

Shares advanced 5% to 34p on Monday at noon.

Quick facts: Braveheart Investment Group

Price: 54.5 GBX

Market: AIM
Market Cap: £19.76 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...


Braveheart Investment Group Pharm2Farm designs antiviral face mask to kill...

Braveheart Investment Group PLC (LON:BRH) investee company Pharm2Farm's (P2F) Gareth Cave talks to Proactive London about their new antiviral face mask that can kill coronavirus (COVID-19). Cave talks through the technology behind the mask, which is says is much stronger than the standard...

on 26/10/20

2 min read